Real-world effectiveness of early molnupiravir or nirmatrelvir–ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study

BACKGROUND: Data on the effectiveness of oral antivirals in patients with mild-to-moderate COVID-19 are urgently needed. This retrospective cohort study aimed to evaluate the clinical and virological outcomes associated with molnupiravir or nirmatrelvir–ritonavir use in hospitalised patients with mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Carlos K H, Au, Ivan C H, Lau, Kristy T K, Lau, Eric H Y, Cowling, Benjamin J, Leung, Gabriel M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401976/
https://www.ncbi.nlm.nih.gov/pubmed/36029795
http://dx.doi.org/10.1016/S1473-3099(22)00507-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401976/
https://www.ncbi.nlm.nih.gov/pubmed/36029795
http://dx.doi.org/10.1016/S1473-3099(22)00507-2

Ejemplares similares